Viewing Study NCT04950504


Ignite Creation Date: 2025-12-24 @ 9:11 PM
Ignite Modification Date: 2025-12-29 @ 5:45 AM
Study NCT ID: NCT04950504
Status: TERMINATED
Last Update Posted: 2023-09-18
First Post: 2021-06-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-201 in Subjects Ages 16-35 With Peanut Allergy
Sponsor: COUR Pharmaceutical Development Company, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module